Xiaogeng Cheng

Title: Innovations by Xiaogeng Cheng in Vaccine Development

Introduction

Xiaogeng Cheng is a notable inventor based in Changchun, China. He has made significant contributions to the field of vaccine development, particularly in creating innovative compositions for live attenuated influenza vaccines. His work is characterized by a focus on enhancing vaccine efficacy and safety.

Latest Patents

Xiaogeng Cheng holds a patent for a "Non-gelatin vaccine protectant composition and live attenuated influenza vaccine." This invention provides a composition for use as a protectant for a live attenuated influenza virus vaccine. The composition includes human serum albumin at concentrations of 1.0-15.0 g/L, sugar at 15.0-95.0 g/L, and sodium glutamate at 0.5-15.0 g/L. The process for preparing the vaccine involves dissolving these components in a pH buffer solution, adjusting the pH, performing filtration sterilization, and adding virus stock. The resulting vaccine can be administered as an injection or nasal spray.

Career Highlights

Xiaogeng Cheng is associated with Changchun Bcht Biotechnology Co., where he continues to advance his research in vaccine technology. His innovative approach has led to the development of effective vaccine formulations that address public health needs.

Collaborations

Xiaogeng Cheng collaborates with esteemed colleagues, including Zhenwei Shen and Xiaohui Chen. Their combined expertise contributes to the ongoing research and development efforts in the biotechnology sector.

Conclusion

Xiaogeng Cheng's contributions to vaccine development exemplify the importance of innovation in public health. His patented work on non-gelatin vaccine protectants showcases his commitment to improving vaccine formulations and enhancing their effectiveness.